15,99 €
Statt 18,95 €**
15,99 €
inkl. MwSt.
**Preis der gedruckten Ausgabe (Broschiertes Buch)
Sofort per Download lieferbar
payback
0 °P sammeln
15,99 €
Statt 18,95 €**
15,99 €
inkl. MwSt.
**Preis der gedruckten Ausgabe (Broschiertes Buch)
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
0 °P sammeln
Als Download kaufen
Statt 18,95 €****
15,99 €
inkl. MwSt.
**Preis der gedruckten Ausgabe (Broschiertes Buch)
Sofort per Download lieferbar
payback
0 °P sammeln
Jetzt verschenken
Statt 18,95 €****
15,99 €
inkl. MwSt.
**Preis der gedruckten Ausgabe (Broschiertes Buch)
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
0 °P sammeln
  • Format: ePub

Essay from the year 2007 in the subject Business economics - Business Management, Corporate Governance, grade: 69% - B, University of Sunderland (Faculty of Business and Law), course: Innovation & Growth, language: English, abstract: Pfizer Inc. is taken as case study for an innovative company in the pharmaceutical sector. Firstly, the author will look at its mission statement in relation to its key stakeholders. Secondly, the company's overall strategy will be outlined regarding its positioning on the market as well the linkage to key theories which will be discussed and applied. The third…mehr

  • Geräte: eReader
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 0.51MB
Produktbeschreibung
Essay from the year 2007 in the subject Business economics - Business Management, Corporate Governance, grade: 69% - B, University of Sunderland (Faculty of Business and Law), course: Innovation & Growth, language: English, abstract: Pfizer Inc. is taken as case study for an innovative company in the pharmaceutical sector. Firstly, the author will look at its mission statement in relation to its key stakeholders. Secondly, the company's overall strategy will be outlined regarding its positioning on the market as well the linkage to key theories which will be discussed and applied. The third part focuses on Pfizer's operational issues. Finally a comparison of the strategic performance and application of theories between Microsoft and Pfizer, both, two highly innovative companies, will be made. Pfizer, as the main case study, was chosen, because it can be defined as a highly innovative company, ranking globally the second by R&D expenditure on the DTI R&D scoreboard (see Appendix 1). However, according to the 'Business Week' the company ranks only on place 55 in the world's most innovative companies, with a margin growth of 1.8% and stock returns of 9.9% between 1995 till 2005. (Business Week, 2006) This provides the evidence that Pfizer is an innovative company.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.